Xpovio (selinexor)

pCPA File Number: 21962

Negotiation Status:

Concluded with an LOI

Indication(s):

For the treatment of adult patients, in combination with bortezomib (V) and dexamethasone (d), with multiple myeloma (MM) who have received at least one prior therapy.

Sponsor/Manufacturer:

Forus Therapeutics Inc.

CADTH Project Number:

PC0276

pCPA Engagement Letter Issued:

2022-12-20

Negotiation Process Concluded:

2023-05-15